Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2023

Stockholders' Equity Note [Abstract]

Schedule of Stock Options Activity

A summary of the stock option activity under the Company’s equity incentive plans is presented below:

	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Term	Aggregate Intrinsic Value
Balance as of December 31, 2022	3,976	$	6.20	3.80	$	—
Granted	51	0.61		—	—
Exercised	(34)	0.86		—	—
Forfeited	(132)	5.18		—	—
Expired	(143)	5.05		—	—
Balance as of June 30, 2023	3,718	$	6.25	3.11	$	—
Expected to vest at June 30, 2023	3,718	$	6.25	3.11	$	—
Exercisable at June 30, 2023	3,235	$	6.46	2.28	$	—

Schedule of RSU Activity

A summary of Restricted Stock Unit (“RSU”) activity is presented below:

	Shares	Weighted Average Grant- Date Fair Value
Outstanding as of December 31, 2022	7,495	$	3.59
Granted	8,819	0.63
Vested	(2,052)	4.03
Forfeited	(1,264)	4.60
Outstanding as of June 30, 2023	12,998	$	1.41

Summary of Stock-Based Compensation Expense

The following table summarizes stock-based compensation cost included in the condensed consolidated statements of operations:

	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Cost of revenue, excluding depreciation and amortization	$	255	$	2,695	$	611	$	3,155
Sales and marketing	318		1,391		887		2,113
General and administrative	1,612		3,782		2,154		6,380
Research and development1	72		3,416		(273)		3,576
Total	$	2,257	$	11,284	$	3,379	$	15,224

_________________________________

(1) The negative stock-based compensation expense for the six months ended June 30, 2023 for Research and development was due to forfeitures.